| Product Code: ETC9613223 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Angiogenesis Inhibitors Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Angiogenesis Inhibitors Market - Industry Life Cycle |
3.4 Taiwan Angiogenesis Inhibitors Market - Porter's Five Forces |
3.5 Taiwan Angiogenesis Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Taiwan Angiogenesis Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Taiwan Angiogenesis Inhibitors Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Taiwan Angiogenesis Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Taiwan Angiogenesis Inhibitors Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Taiwan Angiogenesis Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Taiwan Angiogenesis Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and related diseases in Taiwan |
4.2.2 Growing investments in research and development for innovative angiogenesis inhibitors |
4.2.3 Rising adoption of targeted therapies for cancer treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Taiwan |
4.3.2 High cost associated with angiogenesis inhibitors treatment |
4.3.3 Limited awareness and access to advanced cancer therapies in certain regions of Taiwan |
5 Taiwan Angiogenesis Inhibitors Market Trends |
6 Taiwan Angiogenesis Inhibitors Market, By Types |
6.1 Taiwan Angiogenesis Inhibitors Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By VEGF Targeted Therapy, 2021- 2031F |
6.1.4 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By FGF Targeted Therapies, 2021- 2031F |
6.1.5 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Oncogene Targeted Therapy, 2021- 2031F |
6.1.6 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Matrix Degrading and Remodeling Targeted Therapy, 2021- 2031F |
6.1.7 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Taiwan Angiogenesis Inhibitors Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.2.3 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.4 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Taiwan Angiogenesis Inhibitors Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Inlyta, 2021- 2031F |
6.3.3 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Avastin, 2021- 2031F |
6.3.4 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Revlimid, 2021- 2031F |
6.3.5 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Taiwan Angiogenesis Inhibitors Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Taiwan Angiogenesis Inhibitors Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Taiwan Angiogenesis Inhibitors Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Taiwan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan Angiogenesis Inhibitors Market Import-Export Trade Statistics |
7.1 Taiwan Angiogenesis Inhibitors Market Export to Major Countries |
7.2 Taiwan Angiogenesis Inhibitors Market Imports from Major Countries |
8 Taiwan Angiogenesis Inhibitors Market Key Performance Indicators |
8.1 Number of ongoing clinical trials for angiogenesis inhibitors in Taiwan |
8.2 Percentage of healthcare professionals trained in prescribing and administering angiogenesis inhibitors |
8.3 Patient survival rates and quality of life improvements post angiogenesis inhibitors treatment |
9 Taiwan Angiogenesis Inhibitors Market - Opportunity Assessment |
9.1 Taiwan Angiogenesis Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Taiwan Angiogenesis Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Taiwan Angiogenesis Inhibitors Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Taiwan Angiogenesis Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Taiwan Angiogenesis Inhibitors Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Taiwan Angiogenesis Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Taiwan Angiogenesis Inhibitors Market - Competitive Landscape |
10.1 Taiwan Angiogenesis Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Angiogenesis Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here